Ameriprise’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$478M Sell
6,759,903
-189,494
-3% -$14.2M 0.11% 200
2025
Q4
$549M Sell
6,949,397
-796,944
-10% -$63.1M 0.12% 173
2025
Q3
$640M Buy
7,746,341
+352,395
+5% +$27.7M 0.15% 146
2025
Q2
$594M Sell
7,393,946
-12,566
-0.2% -$970K 0.15% 149
2025
Q1
$594M Buy
7,406,512
+259,993
+4% +$21.6M 0.16% 139
2024
Q4
$585M Sell
7,146,519
-45,931
-0.6% -$3.82M 0.15% 146
2024
Q3
$594M Sell
7,192,450
-718,984
-9% -$53.7M 0.15% 150
2024
Q2
$555M Sell
7,911,434
-585,380
-7% -$41.8M 0.15% 147
2024
Q1
$630M Sell
8,496,814
-1,090,454
-11% -$76M 0.17% 126
2023
Q4
$634M Sell
9,587,268
-967,888
-9% -$60.6M 0.19% 113
2023
Q3
$666M Sell
10,555,156
-333,940
-3% -$20.8M 0.22% 96
2023
Q2
$615M Buy
10,889,096
+309,977
+3% +$17.2M 0.19% 112
2023
Q1
$612M Sell
10,579,119
-885,976
-8% -$59.8M 0.2% 119
2022
Q4
$830M Sell
11,465,095
-468,332
-4% -$33.5M 0.28% 87
2022
Q3
$727M Sell
11,933,427
-417,835
-3% -$26.7M 0.27% 87
2022
Q2
$773M Buy
12,351,262
+985,442
+9% +$65.2M 0.27% 83
2022
Q1
$792M Buy
11,365,820
+1,186,546
+12% +$80.2M 0.23% 89
2021
Q4
$628M Buy
10,179,274
+821,941
+9% +$51.6M 0.17% 120
2021
Q3
$578M Sell
9,357,333
-174,823
-2% -$10.5M 0.18% 116
2021
Q2
$570M Buy
9,532,156
+921,083
+11% +$58.4M 0.18% 121
2021
Q1
$525M Sell
8,611,073
-146,679
-2% -$8.09M 0.17% 124
2020
Q4
$412M Sell
8,757,752
-382,911
-4% -$16.6M 0.15% 148
2020
Q3
$340M Sell
9,140,663
-785,355
-8% -$29.8M 0.14% 158
2020
Q2
$363M Sell
9,926,018
-635,932
-6% -$22.1M 0.16% 139
2020
Q1
$323M Buy
10,561,950
+2,312,380
+28% +$103M 0.17% 131
2019
Q4
$420M Sell
8,249,570
-170,678
-2% -$8.24M 0.17% 126
2019
Q3
$397M Sell
8,420,248
-350,658
-4% -$16.7M 0.18% 115
2019
Q2
$436M Buy
8,770,906
+150,960
+2% +$7.1M 0.2% 107
2019
Q1
$367M Buy
8,619,946
+1,178,235
+16% +$52.1M 0.17% 124
2018
Q4
$306M Sell
7,441,711
-164,868
-2% -$7.07M 0.15% 144
2018
Q3
$387M Buy
7,606,579
+749,850
+11% +$34.3M 0.14% 172
2018
Q2
$299M Sell
6,856,729
-1,753,161
-20% -$81.7M 0.13% 171
2018
Q1
$396M Sell
8,609,890
-807,043
-9% -$39.2M 0.18% 126
2017
Q4
$476M Sell
9,416,933
-14,239
-0.2% -$750K 0.22% 97
2017
Q3
$489M Sell
9,431,172
-2,440,443
-21% -$119M 0.23% 92
2017
Q2
$582M Sell
11,871,615
-401,593
-3% -$18.6M 0.29% 75
2017
Q1
$577M Buy
12,273,208
+106,446
+0.9% +$5.07M 0.3% 68
2016
Q4
$585M Buy
12,166,762
+4,927,013
+68% +$226M 0.32% 59
2016
Q3
$287M Sell
7,239,749
-1,234,536
-15% -$46.4M 0.16% 138
2016
Q2
$300M Buy
8,474,285
+804,118
+10% +$31.4M 0.18% 125
2016
Q1
$300M Sell
7,670,167
-866,898
-10% -$32.4M 0.18% 127
2015
Q4
$367M Sell
8,537,065
-4,220,802
-33% -$186M 0.22% 99
2015
Q3
$536M Sell
12,757,867
-1,356,693
-10% -$63.4M 0.33% 70
2015
Q2
$704M Buy
14,114,560
+3,310,563
+31% +$157M 0.4% 54
2015
Q1
$487M Buy
10,803,997
+2,183,706
+25% +$98.1M 0.28% 76
2014
Q4
$416M Sell
8,620,291
-1,121,254
-12% -$53.3M 0.24% 102
2014
Q3
$466M Sell
9,741,545
-1,384,804
-12% -$67.3M 0.28% 78
2014
Q2
$551M Buy
11,126,349
+673,724
+6% +$31.5M 0.33% 64
2014
Q1
$492M Buy
10,452,625
+1,691,358
+19% +$77.7M 0.3% 78
2013
Q4
$421M Sell
8,761,267
-3,280,562
-27% -$147M 0.26% 97
2013
Q3
$504M Sell
12,041,829
-1,029,121
-8% -$44.3M 0.33% 57
2013
Q2
$533M Buy
+13,070,950
New +$481M 0.37% 48

Other funds holding MET

Ameriprise's MET Position: Q1 2026 in Review

Ameriprise reduced its MetLife (MET) stake by 2.7% in Q1 2026, selling an estimated $14.2M and leaving 6,759,903 shares worth $478M. The position accounts for 0.11% of the portfolio, ranked #200.

Ameriprise first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $830M in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Ameriprise held 6,759,903 shares of MetLife worth $478M as of Q1 2026.
  • Ameriprise sold 189,494 MetLife shares in Q1 2026, an estimated $14.2M.
  • MetLife made up 0.11% of Ameriprise's portfolio in Q1 2026, its #200 holding.
  • Ameriprise first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's MetLife position peaked at $830M in Q4 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.